Burning Rock Biotech Files 6-K for March 2025
Ticker: BNR · Form: 6-K · Filed: Mar 25, 2025 · CIK: 1792267
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Burning Rock Biotech filed a 6-K for March 2025, incorporating Exhibit 99.1.
AI Summary
Burning Rock Biotech Limited filed a Form 6-K on March 25, 2025, to incorporate by reference certain information from Exhibit 99.1. This filing is for the month of March 2025 and is required for foreign private issuers. The company's principal executive offices are located in Guangzhou, People's Republic of China.
Why It Matters
This filing indicates ongoing reporting requirements for Burning Rock Biotech Ltd as a foreign private issuer, providing updates to the SEC.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not appear to contain new material financial or operational information.
Key Players & Entities
- Burning Rock Biotech Limited (company) — Registrant
- 001-39316 (company) — Commission File Number
- Exhibit 99.1 (document) — Incorporated by reference
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is a report of a foreign private issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of March 2025, incorporating Exhibit 99.1 by reference.
What is the company's name and file number?
The company's name is Burning Rock Biotech Limited, and its SEC Commission File Number is 001-39316.
Where are Burning Rock Biotech's principal executive offices located?
The principal executive offices are located at No.5 Xingdao Ring Road North, International Bio Island, Guangzhou, Guangdong, People's Republic of China.
What specific exhibit is being incorporated by reference?
Exhibit 99.1 is being incorporated by reference, with specific exclusions for paragraphs under 'Non-GAAP Measures' and related tables.
Does the company file annual reports under Form 20-F or 40-F?
The registrant indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 25, 2025 regarding Burning Rock Biotech Ltd (BNR).